key: cord-1049109-i9apa2gf authors: Paniri, Alireza; Hosseini, Mohammad Mahdi; Eslam, Mojtaba Moballegh; Akhavan-Niaki, Haleh title: Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations date: 2020-12-04 journal: Gene Rep DOI: 10.1016/j.genrep.2020.100979 sha: 47bf57c67a3628848972ac05f0a0a70391a29e0b doc_id: 1049109 cord_uid: i9apa2gf The COVID-19 pandemic emerges a reminder that wide spectrum discrepancy in response to SARS-CoV-2 infection and antiviral drugs among different populations might be due to their different ACE2 SNPs and/or miRNAs profile. ACE2 is the major component for SARS-CoV-2s' cell entry, and disruption of its 3D structure could influence virus-ACE2 interaction. In this study we aimed to investigate the consequence of 16,860 SNPs within ACE2 on its expression as well as protein folding, function, and stability by using several beneficial bioinformatics tools. Only 64 SNPs including 60 intronic, and 4 missense showed different frequencies among different populations. Two missense SNPs including rs149039346 and rs147311723 have been predicted to strongly influence the function and stability of ACE2. rs1514283 creates new acceptor splice site. Also, rs4646175 creates new donor and acceptor splice site. PolymiRTS, and miRSNPs have predicted that rs3746444, rs113808830, and rs3751304 showed a MAF > 0.001, and disrupted mRNA target sites or mRNA function. Finally, rs3746444 hsa-miR-499a-3p, rs113808830 hsa-miR-4532, rs3751304 hsa-miR-6763-3p and hsa-miR-26b-5p were strongly hybridized with ACE2 and might influence its function. Collectively, this study shed some light on fundamental roles of ACE2 SNPs for its interaction with COVID-19, and consequently susceptibility to virus. Therefore, different responses of patients with COVID-19 to ACE2 blocker drugs might be due to their unique ACE2 SNPs. We further discussed the impact of SNPs on miRNAs profile as a factor that may modulate drug response or susceptibility to COVID-19. J o u r n a l P r e -p r o o f Journal Pre-proof Sorting intolerant from tolerant (SIFT) (https://sift.bii.a-star.edu.sg/) is able to investigate the probable consequence of amino acids substitution (non-synonymous polymorphisms) on protein folding in human genome and non-human organisms as previously described (6). SIFT shows deleterious and benign substitutions with scores ranging from 0 to 0.05 and 0.05 to 1, respectively. Polymorphism phenotyping v2 (PolyPhen-2) (http://genetics.bwh.harvard.edu/pph2/), is another analyzer of effects of amino acid substitution on functional and structural proteins as previously described (6). Scores ranging from 0.0 to 0.15, 0.15 to 0.85, and 0.85 to 1.0 are considered benign, possibly damaging, and damaging, respectively. Protein variation effect analyzer (PROVEAN) (http://provean.jcvi.org/index.php) is a in silico database to investigation the impact of amino acid substitutions and on functions and structure of proteins as previously described (6). A score <-2.5 represents a "deleterious" variant while a score>-2.5 corresponds to a "neutral" variant. Analysis of functional impacts of SNPs by Screening for Non-acceptable Polymorphisms (SNAP2) (https://www.rostlab.org/services/snap/) is another free accessible bioinformatics tool that analyzes the impacts of different SNPs on protein function as previously described (6). In heat map, a score equal to -100 (dark blue) and +100 (dark red) depicts that amino acid substitution is completely neutral and pathogenic, respectively. clusters the impacts of SNPs on the disease and scores vary between 0 and 9. The required inputs are including protein sequence, position, and new residue. Protein Analysis Through Evolutionary Relationship (PANTHER) (available at https://www.pantherdb.org/) is a database that uses protein sequences in FASTA forma,t and can analyze substitution changes. It calculates the protein function alterations resulting from SNPs with Substitution Position-Specific Evolutionary Conservation (subPSEC) scores. A score less than -3 is predicted deleterious while 0 is predicted to be benign. Functional Analysis of SNPs through Hidden Markov Models (Fathmm) https://fathmm.biocompute.org.uk/, is a powerful tool that calculates SNPs scores, and disorders related to blood, development, ear, nose and throat, endocrine, eye, heart, as well as nervous, genitourinary, immune, and musculoskeletal systems, and etc. iPTREE-STAB available at http://210.60.98.19/IPTREEr/iptree.htm is a valuable tool that could predict and analyze the protein stability alterations (with the ΔΔG values) upon single nucleotide variation accompanied with high accuracy (%82) and high correlation coefficient (0.70) between predicted and experimental values. Necessary inputs for iPTREE-STAB are including deleted-residue mutation type, introduced-residue mutation type, and the neighbors found inside a symmetrical window centered at the mutated residue. Human splicing finder (HSF) is an advantageous software (http://www.umd.be/HSF/) that is able to forecast the disruption of the natural splice sites, and identify splicing motifs in all human sequence as previously described (6). For donor or acceptor splicing site recognition, HSF applies "position weight matrices" algorithm with consensus values (CV) that extend J o u r n a l P r e -p r o o f from 0 to 100. CVs higher than 65 are predicted as acceptor or donor splicing site. Moreover, wild type sequence score higher than 65 along with variation score less than -10% predicts that the mutation represents a new splice site. Moreover, a wild type sequence score less than 65 along with variation score higher than +10%, predicts the creation of a new splice site. I-TASSER available at (https://zhanglab.ccmb.med.umich.edu/I-TASSER/) is a strong predictor of protein 3D structure. I-TASSER aims to determine by computational calculations the spatial location of every atom in a protein molecule from the amino acid sequence. The main purpose of I-TASSER is analyzing the iterative protein structure assembly along with prediction of solvent accessibility, normalized B-factor, ligand binding sites, and enzyme commission (EC) numbers and its active sites. Phobius (http://phobius.sbc.su.se/) is a combined predictor of transmembrane topology and signal peptide following amino acid substitution via analyzing the amino acid sequence. Phobius releases the results in form of a plot by calculating the total probability that a residue may belong to a helix, cytoplasmic or non-cytoplasmic domain. PolymiRTS (available at http://compbio.uthsc.edu/miRSNP/) was used to predict the impacts of polymorphism on miRNA seed regions and its targeting profiling. MiRSNPs (http://bioinfo.bjmu.edu.cn/mirsnp/search/) is another suitable tool for analyzing the effect of polymorphisms on miRNAs profile that identifies more than 414,000 SNPs and their possible affects on miRNA-mRNA binding. MiRSNPs also provides results with a specific miRNA-mRNA binding energy with higher scores representing a more stable miRNA-mRNA binding. Morover, miRTarBase (http://mirtarbase.cuhk.edu.cn/php/index.php) predicts targets of large number of genes via reporter assay, western blot, qPCR, microarray, next generation sequencing, and pulsed-SILAC (pSILAC). RNAhybrid v2.1.2 RNAhybrid (https://bibiserv.cebitec.uni-bielefeld.de/rnahybrid/) is a tool for finding the minimum free energy hybridization of a long and a short RNA. The hybridization is performed in a kind of domain mode, ie. the short sequence is hybridized to the best fitting part of the long one. The tool was primarily meant as a mean for miRNA target prediction. Achieved results from Ensembl have demonstrated that ACE2 is located on Xp22.2, and contains 19 exons. It also indicated contigs, regulatory elements such as promoter, enhancer, CCCTC-binding factor (CTCF), and coding and non-coding regions ( Fig 1A) . Furthermore, J o u r n a l P r e -p r o o f Journal Pre-proof ACE2 structural variants types and their position including copy number variation (CNV), gain, insertion, deletion, duplication, and tandem duplication are shown in Fig 1B. Also, Gtex provided ACE2 location and eQTL categorizing of all ACE2 variants and their effects on ACE2 expression levels along with normalized effect size (NES) for several tissues including adipose-subcutaneous (ADPSBQ), adipose-visceral (Omentum) (ADPVSC), artery-tibial (ARTTBL), brain-amygdala (BRNAMY), brain-anterior cingulate cortex (BA24) (BRNACC), brain-caudate (basal ganglia) (BRNCDT), etc (Fig 2A and B) . Moreover, it showed that ACE2 is highly expressed in small intestine-terminal lumen, adipose visceral, testis, breast, and adipose subcutaneous tissues while it is weakly expressed in spleen, and pituitary gland. Gtex also have demonstrated that median read count per base for exons 12-16, 18, and 19 in testis and small intestine-terminal lumen is remarkably higher than other tissues ( Fig 2C) . Sequences of ACE2 isoforms were retrieved from UniPort. Further, the molecular function and pathways of ACE2 were investigated through KEGG (Fig 3) , and GO (Table S1 ). NCBI was exploited to achieve all SNPs throughout the ACE2 along with SNPs J o u r n a l P r e -p r o o f and 2 missense SNPs including rs4646116, and rs41303171 presented a different frequency in European population relative to other populations ( Fig 5) . Several bioinformatics tools including SIFT, PolyPhen-2, PROVEAN, SNAP2, PhD-SNP, PANTHER, FTHMM, and iPTREE were involved to investigation of effect of 4 missense SNPs (rs4646116, rs41303171, rs147311723, and rs149039346) on protein function and stability ( (Table 2) . Several powerful databases such as Phyre2, GOR IV and PSIPRED were exploited to prediction of ACE2 SNPs on secondary structure of ACE2. They showed that ACE2 is mainly constituted by alpha helix (44.1%), and random coil (39.63%) ( Fig S1) . Moreover, obtained results from Phyre2 have illustrated that rs149039346 (S > P) is located in disorder region with relatively high confidence, and change of serine into proline increases the possibility of disorder ( Fig S2) . J o u r n a l P r e -p r o o f I-TASSER was exploited to analyze the3D structure of ACE2 following different SNPs. The 3D structure of wild type ACE2 was analyzed and compared with rs149039346 ser692pro, and rs147311723 L731F. I-TASSER predicted that B-factor didn't show any change between wild type and ACE2 with different SNPs. B-factor is a value to indicate the extent of the inherent thermal mobility of residues/atoms in proteins. Also, results showed that solvent accessibility for rs149039346 and rs147311723 were 3 and 1, respectively and were similar to wild type ACE2. It revealed that possible ligand binding site residues for wild type ACE2 are 151, 167, 168, 169, 228, 229, 230, 231, 232, 233, 234, 373, 381, 412, 413, 416, 522 (Fig 7A) . Moreover it indicated that possible ligand binding residues were changing upon rs149039346 and rs147311723, and were 273, 274, 350, 378, 382, 402, 449, 503, 504, 505, 510, 512, and 515 and 273, 274, 378, 382, 402, 449, 503, 504, 505, 510, 512 , and 515, respectively (Fig 7 B and C) . I-TASSER also reported that enzyme commission (EC) numbers and active sites (402, and 515) were similar between wild type ACE2 and rs149039346 and rs147311723 ( Fig 7D) . Investigation of impacts of ACE2 SNPs on PTM have showed that some of ACE2 residues may undergo modifications including acetylation, farnesylation, N-linked glycosylation, pupylation, ADP-ribosylation, geranylgeranylation, N-terminal acetylation, addition of pyrrolidone carboxylic acid, amidation, GPI-anchor amidation, O-linked glycosylation, sulfation, C-linked glycosylation, hydroxylation, palmitoylation, SUMOylation, carboxylation, methylation, phosphorylation, ubiquitination, disulfide linkage, myristoylation, andproteolytic cleavage (Fig 8) . Among all modified residues neither of them showed a MAF > 0.001. Study of changes in secretion of ACE2 upon SNPs including rs4646116, rs41303171, rs147311723, and rs149039346 were performed by phobius which revealed that they didn't influence ACE2 secretion (Fig 9) . (Table 3) . Among these 3 SNPs rs3746444 disrupted miRNA seeds target, rs113808830 and rs3751304 created miRNA seeds target. Furthermore, miRSNPs predicted two SNPs comprising rs182366225, and rs142017934 that were predicted by PolymiRTS and showed similar frequency among different population (Table 3D ). Finally, miRTarBase by Microarray forecasted that hsa-miR-26b-5p strongly targeted ACE2 with high confidency. Moreover, investigation of ACE2 secondary structure through hyre2, GOR IV, and PSIPRED showed that rs4646116 (K26R), rs41303171 (N720D), rs147311723 (L731F), and rs149039346 (S692P) were located in helix, coil, coil, and helix structure, respectively. Surprisingly, Phyre2 revealed that S692P probably caused disorder with relatively high confidence. Therefore, change in ACE2 structure might influence COVID-19 cell entry, and consequently its replication in host cells especially lung (Sommerstein al, 2020 significantly associated with increased risk of cancer of the respiratory system. Also, they have found a significant association between microRNA-499 rs3746444 and cancer risk in Asians but not Caucasians (Chen et al., 2014) . Accordingly, there is some evidence about the fundamental role of rs3746444 in microRNA-499 in pathogenesis of other caners including breast and prostate with significant association in Asian population but not Caucasians (Kabirizadeh et al., 2016; Mi et al., 2018; Tan et al., 2020; Zou et al., 2012) . Furthermore, miRTarBase have predicted that hsa-miR-26b-5p strongly targeted ACE2. Correspondingly, increasing body of evidence demonstrated the crucial role of miR-26a in combat with several J o u r n a l P r e -p r o o f viral infections including Herpes virus, Influenza A, and H1N1 Influenza A (Gao et al., 2017; Nguyen et al., 2018; Song et al, 2010; . Data from RNA-seq analysis indicated that miR-26a significantly increased innate anti-viral responses such as type I interferon (IFN), and IFN-stimulated genes expression. Further investigation showed that miR-26a potentially inhibits the replication of porcine reproductive and respiratory syndrome virus by inducing innate antiviral immunity (Jia et al., 2015) . Strikingly, achieved results from RNAhybrid v2.1.2 have illustrated that these miRNAs are able to bind ACE2 transcript with high stability. Taken together, RNAhybrid v2.1.2 have raised the possibility that ACE2 expression and its folding are more influenced by SNPs located in non-coding regions in comparison with those located in coding regions including missense and nonsense SNPs. In contrast to our results a recent study has reported that ACE2 expression and polymorphisms didn't show any significant difference between Asians and other populations. This discrepancy might be due to the fact that the fundamental role of SNPs in miRNAs expression and function as well as the impact of SNPs on ACE2 splicing processes were ignored in the corresponding study . Collectively, as we are at the COVID-19 influenced some populations more than others, and caused relatively higher mortality and morbidity in these zones including East Asia, America, and Europe. Broad spectrum of patient's manifestations emerges this hypothesis that different ACE2 SNPs may be responsible for this discrepancy. ESA: East Asia; AFR: Africa EUA: Europe. ligand binding site residues predicted as 151, 167, 168, 169, 228, 229, 230, 231, 232, 233, 234, 373, 381, 412, 413, 416, 522; (B) 3D structure of ACE2 with rs149039346 (S692P) and possible ligand binding site residues predicted as 273, 274, 350, 378, 382, 402, 449, 503, 504, 505, 510, 512 , and 515; (C) 3D structure of ACE2 with rs147311723 (L731F) and possible ligand binding site residues predicted as 151, 167, 168, 169, 228, 229, 230, 231, 232, 233, 234, 373, 381, 412, 413, 416, 522; (D) Enzyme commission (EC) numbers and active sites (402, and 515) are shown for native ACE2 and with rs149039346 and rs147311723. B-factor is a value indicating the extent of the inherent thermal mobility of residues/atoms in proteins. Based on the distributions and predictions of the B-factor profile (BFP), residues with BFP values higher than 0 are less stable in experimental structures. J o u r n a l P r e -p r o o f ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin Meta-analysis of Hsamir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies Asians do not exhibit elevated expression or unique genetic polymorphisms for ACE2, the cell-entry receptor of SARS-CoV-2 Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin J o u r n a l P r e -p r o o f II type 1 receptor downregulation Influenza A virus-induced downregulation of miR-26a contributes to reduced IFNα/β production Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2 Large-scale proteomics and phosphoproteomics of urinary exosomes SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the SARS-coronavirus spike-protein TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein Cloning and characterization of a secreted form of angiotensin-converting enzyme Cloning and characterization of a secreted form of angiotensin-converting enzyme 2 Cellular microRNA miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by activating innate antiviral immunity The SNP rs3746444 within mir-499a is associated with breast cancer risk in Iranian population Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management Long non-coding RNAs: Novel links in respiratory diseases Lipid rafts are involved in SARS-CoV entry into Vero E6 cells Coronaviruses and SARS-CoV-2: A Brief Overview The association between three genetic variants in MicroRNAs (Rs11614913, Rs2910164, Rs3746444) and prostate cancer risk Potential role of MicroRNAs in the regulation of antiviral responses to influenza infection First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine ACE2: a new target for cardiovascular disease therapeutics Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19 A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 COVID-19, ACE2, and the cardiovascular consequences The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.J o u r n a l P r e -p r o o f